Literature DB >> 35111601

Perivascular space is associated with brain atrophy in patients with multiple sclerosis.

Xue-Yu Liu1, Gai-Ying Ma1, Shi Wang1, Qian Gao1, Cong Guo1, Qiao Wei1, Xuan Zhou1, Li-Ping Chen1.   

Abstract

BACKGROUND: Perivascular space (PVS) is associated with neurodegenerative and neuroimmune diseases. Multiple sclerosis (MS) is traditionally a neuroimmune disease. However, studies show neurodegeneration also plays a vital role in MS. At present, most studies conclude severer PVS in MS is an imaging marker of neuroinflammation, while a 7T MRI study suggests that PVS in MS is associated with neurodegeneration.
METHODS: In this study, 82 MS patients (n=82) and 32 healthy controls (n=32) were enrolled. The following indexes were measured: the number, size and distribution of PVS, the PVS score, corpus callosum index (CCI), corpus callosum area (CCA), the ratio of the corpus callosum to the cranium (CCR), aligned third ventricle width (a3VW), and unaligned third ventricle width (u3VW).
RESULTS: The PVS score (4 vs. 3, P=0.041), PVSs number (103.280±45.107 vs. 87.625±30.139, P=0.035), and enlarged perivascular spaces (EPVSs) number (9 vs. 1, P<0.001) of MS patients were significantly higher than in the healthy controls. PVSs number (23.5 vs. 13) and EPVSs number (1 vs. 0) in the basal ganglia (BG), and EPVSs number (3 vs. 0) in centrum semiovale (CSO) of MS patients were significantly higher than in the healthy controls, P<0.001. In MS patients, PVS was correlated with age and hypertension but not to the extended disability status scale (EDSS) score and other clinical data. In MS patients, PVS score was correlated with CCA (rs=0.272; P=0.013) and the CCR (rs=0.219; P=0.048), and PVSs number was correlated with CCA (rs=0.255; P=0.021), the correlation disappeared after adjusting hypertension and age. In MS patients in remission, PVSs number was correlated with CCA (rs=0.487; P=0.019), CCR (rs=0.479; P=0.021), and PVS score was correlated with CCA (rs=0.453; P=0.03). After adjustment of hypertension and age, the total number of PVSs was correlated with CCA (rs=0.419; P=0.049).
CONCLUSIONS: The PVS load in MS patients was heavier than healthy people, especially in BG and CSO. PVS was not correlated with EDSS in MS patients. The PVS of MS patients was associated with CCA and CCR, and PVSs number was independently related with CCA in MS patients in remission. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Perivascular space (PVS); brain atrophy; multiple sclerosis (MS); neurodegeneration; neuroinflammation

Year:  2022        PMID: 35111601      PMCID: PMC8739126          DOI: 10.21037/qims-21-705

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  41 in total

Review 1.  Immunological and neuropathological significance of the Virchow-Robin space.

Authors:  M M Esiri; D Gay
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

Review 2.  Virchow-Robin spaces at MR imaging.

Authors:  Robert M Kwee; Thomas C Kwee
Journal:  Radiographics       Date:  2007 Jul-Aug       Impact factor: 5.333

3.  The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry.

Authors:  Stella Hughes; Timothy Spelman; Maria Trojano; Alessandra Lugaresi; Guillermo Izquierdo; Francois Grand'maison; Pierre Duquette; Marc Girard; Pierre Grammond; Celia Oreja-Guevara; Raymond Hupperts; Cavit Boz; Roberto Bergamaschi; Giorgio Giuliani; Maria Edite Rio; Jeannette Lechner-Scott; Vincent van Pesch; Gerardo Iuliano; Marcela Fiol; Freek Verheul; Michael Barnett; Mark Slee; Joseph Herbert; Ilya Kister; Norbert Vella; Fraser Moore; Tatjana Petkovska-Boskova; Vahid Shaygannejad; Vilija Jokubaitis; Gavin McDonnell; Stanley Hawkins; Frank Kee; Orla Gray; Helmut Butzkueven
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-12-28       Impact factor: 10.154

4.  Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.

Authors:  M Vaneckova; T Kalincik; J Krasensky; D Horakova; E Havrdova; T Hrebikova; Z Seidl
Journal:  Eur Neurol       Date:  2012-06-06       Impact factor: 1.710

Review 5.  Imaging the Perivascular Space as a Potential Biomarker of Neurovascular and Neurodegenerative Diseases.

Authors:  Joel Ramirez; Courtney Berezuk; Alicia A McNeely; Fuqiang Gao; JoAnne McLaurin; Sandra E Black
Journal:  Cell Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.046

6.  Perivascular spaces in MS patients at 7 Tesla MRI: a marker of neurodegeneration?

Authors:  I D Kilsdonk; M D Steenwijk; P J W Pouwels; J J M Zwanenburg; F Visser; P R Luijten; J J G Geurts; F Barkhof; M P Wattjes
Journal:  Mult Scler       Date:  2014-07-10       Impact factor: 6.312

Review 7.  Iron in multiple sclerosis: roles in neurodegeneration and repair.

Authors:  Erin Stephenson; Nabeela Nathoo; Yasamin Mahjoub; Jeff F Dunn; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

8.  Cortical atrophy is relevant in multiple sclerosis at clinical onset.

Authors:  Massimiliano Calabrese; Matteo Atzori; Valentina Bernardi; Aldo Morra; Chiara Romualdi; Luciano Rinaldi; Matthew J M McAuliffe; Luigi Barachino; Paola Perini; Bruce Fischl; Leontino Battistin; Paolo Gallo
Journal:  J Neurol       Date:  2007-03-14       Impact factor: 4.849

Review 9.  Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Authors:  Houshang Amiri; Alexandra de Sitter; Kerstin Bendfeldt; Marco Battaglini; Claudia A M Gandini Wheeler-Kingshott; Massimiliano Calabrese; Jeroen J G Geurts; Maria A Rocca; Jaume Sastre-Garriga; Christian Enzinger; Nicola de Stefano; Massimo Filippi; Álex Rovira; Frederik Barkhof; Hugo Vrenken
Journal:  Neuroimage Clin       Date:  2018-04-26       Impact factor: 4.881

10.  Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.

Authors:  Zhiqiang Xu; Na Xiao; Yali Chen; Huang Huang; Charles Marshall; Junying Gao; Zhiyou Cai; Ting Wu; Gang Hu; Ming Xiao
Journal:  Mol Neurodegener       Date:  2015-11-02       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.